UK Government signs deal for 60 million doses of potential coronavirus vaccine - which could be ready by 2021

If the deal – with pharmaceutical giants GlaxoSmithKline (GSK) and Sanofi Pasteur – proves successful, the UK could begin to vaccinate priority groups – such as frontline health and social care workers and those at increased risk from coronavirus – as early as the first half of next year, the Department for Business said.

Human clinical studies of the vaccine will begin in September followed by a phase 3 study in December.

The vaccine produced by GSK and Sanofi, which together have the largest vaccine manufacturing capability in the world, is based on the existing DNA-based technology used to produce Sanofi’s seasonal flu vaccine.

The Government has now signed deals for four different types of potential coronavirus vaccines and a total of 250 million doses.

Business Secretary Alok Sharma said: “Our scientists and researchers are racing to find a safe and effective vaccine at a speed and scale never seen before.

“While this progress is truly remarkable, the fact remains that there are no guarantees.

“In the meantime, it is important that we secure early access to a diverse range of promising vaccine candidates, to increase our chances of finding one that works so we can protect the public and save lives.”

Earlier this month, the Government agreed deals with BioNTech, which is working with Pfizer and Valneva for access to their vaccines.

A further agreement has been signed with AstraZeneca and the University of Oxford.

Kate Bingham, chairwoman of the Government’s Vaccines Taskforce, said: “This diversity of vaccine types is important because we do not yet know which, if any, of the different types of vaccine will prove to generate a safe and protective response to Covid-19.

“Whilst this agreement is very good news, we mustn’t be complacent or over-optimistic.

“The fact remains we may never get a vaccine and, if we do get one, we have to be prepared that it may not be a vaccine which prevents getting the virus, but rather one that reduces symptoms.”

A message from the Editor

With the coronavirus lockdown having a major impact on many of our advertisers - and consequently the revenue we receive - we are more reliant than ever on you taking out a digital subscription.

You can subscribe to this website and enjoy unlimited access to local news and information online and on our app.

With a digital subscription, you can read more than 5 articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content.

Simply click ‘Subscribe’ in the menu. You can subscribe to the newspaper with 20% off here.

Thank you.